Breaking News

Today
Show Full Stories

X

To view all stories in expanded form, please subscribe.
Send Info
DRRX

Durect

$1.94

0.04 (2.11%)

07:19
11/18/19
11/18
07:19
11/18/19
07:19
Initiation
Durect initiated at Cantor Fitzgerald »

Durect assumed with an…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 16

    Jan

Thursday
LPCN

Lipocine

$0.69

-0.103 (-13.03%)

09:07
11/14/19
11/14
09:07
11/14/19
09:07
Syndicate
Lipocine 10.45M share Secondary priced at 50c »

Roth Capital acted as…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 14

    Nov

Wednesday
NDRA

Endra Life Sciences

$1.04

0.02 (1.96%)

16:12
11/13/19
11/13
16:12
11/13/19
16:12
Earnings
Endra Life Sciences reports Q3 EPS (46c), consensus (30c) »

Cash at September 30…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

LPCN

Lipocine

$0.68

-0.1103 (-13.96%)

16:00
11/13/19
11/13
16:00
11/13/19
16:00
Syndicate
Lipocine files to sell common stock, no amount given »

Roth Capital Partners is…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Tuesday
LPCN

Lipocine

$0.80

0.0001 (0.01%)

16:01
11/12/19
11/12
16:01
11/12/19
16:01
Earnings
Lipocine reports Q3 EPS (12c), consensus (16c) »

License revenue was…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

DRRX

Durect

$2.08

0.16 (8.33%)

08:46
11/12/19
11/12
08:46
11/12/19
08:46
Hot Stocks
Durect announces results from Phase 2a clinical trial of DUR-928 »

DURECT announced the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 16

    Jan

Over a week ago
LPCN

Lipocine

$0.78

-1.945 (-71.38%)

14:04
11/11/19
11/11
14:04
11/11/19
14:04
Recommendations
Lipocine analyst commentary at H.C. Wainwright »

Lipocine price target…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

LPCN

Lipocine

$0.82

-1.9039 (-69.87%)

13:37
11/11/19
11/11
13:37
11/11/19
13:37
Downgrade
Lipocine rating change at Ladenburg »

Lipocine downgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

CARB

Carbonite

$18.39

0.11 (0.60%)

, OTEX

OpenText

$41.55

0.41 (1.00%)

09:04
11/11/19
11/11
09:04
11/11/19
09:04
Hot Stocks
Fly Intel: Pre-market Movers »

HIGHER: Carbonite (CARB),…

CARB

Carbonite

$18.39

0.11 (0.60%)

OTEX

OpenText

$41.55

0.41 (1.00%)

NKTR

Nektar

$20.04

1.34 (7.17%)

SPWR

SunPower

$8.38

-0.09 (-1.06%)

NNBR

NN, Inc.

$8.78

1.09 (14.17%)

FOLD

Amicus

$8.93

0.01 (0.11%)

QRTEA

Qurate Retail

$9.41

0.18 (1.95%)

FOMX

Foamix

$4.34

0.375 (9.47%)

LPCN

Lipocine

$2.73

-0.065 (-2.33%)

TUP

Tupperware Brands

$9.34

-0.33 (-3.41%)

SMAR

Smartsheet

$39.72

1.91 (5.05%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 11

    Nov

  • 11

    Nov

  • 11

    Nov

  • 11

    Nov

  • 12

    Nov

  • 19

    Nov

  • 21

    Nov

LPCN

Lipocine

$2.73

-0.065 (-2.33%)

06:36
11/11/19
11/11
06:36
11/11/19
06:36
Hot Stocks
Lipocine receives CRL from FDA stating Tlando trial did not meet three endpoints »

Lipocine announced that…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.